Win Hanverky Holdings Balance Sheet Health
Financial Health criteria checks 4/6
Win Hanverky Holdings has a total shareholder equity of HK$1.3B and total debt of HK$464.9M, which brings its debt-to-equity ratio to 34.9%. Its total assets and total liabilities are HK$2.7B and HK$1.4B respectively.
Key information
34.9%
Debt to equity ratio
HK$464.89m
Debt
| Interest coverage ratio | n/a |
| Cash | HK$240.05m |
| Equity | HK$1.33b |
| Total liabilities | HK$1.36b |
| Total assets | HK$2.69b |
Recent financial health updates
Win Hanverky Holdings (HKG:3322) Has Debt But No Earnings; Should You Worry?
Mar 26
Does Win Hanverky Holdings (HKG:3322) Have A Healthy Balance Sheet?
Aug 29Is Win Hanverky Holdings (HKG:3322) A Risky Investment?
Sep 15Recent updates
Here's Why It's Unlikely That Win Hanverky Holdings Limited's (HKG:3322) CEO Will See A Pay Rise This Year
Jun 06Win Hanverky Holdings (HKG:3322) Has Debt But No Earnings; Should You Worry?
Mar 26Does Win Hanverky Holdings (HKG:3322) Have A Healthy Balance Sheet?
Aug 29Is Win Hanverky Holdings (HKG:3322) A Risky Investment?
Sep 15Win Hanverky Holdings' (HKG:3322) Returns On Capital Tell Us There Is Reason To Feel Uneasy
Mar 09Don't Ignore The Fact That This Insider Just Sold Some Shares In Win Hanverky Holdings Limited (HKG:3322)
Mar 06Win Hanverky Holdings' (HKG:3322) Shareholders Are Down 80% On Their Shares
Dec 01
Financial Position Analysis
Short Term Liabilities: 3322's short term assets (HK$1.6B) exceed its short term liabilities (HK$1.2B).
Long Term Liabilities: 3322's short term assets (HK$1.6B) exceed its long term liabilities (HK$161.0M).
Debt to Equity History and Analysis
Debt Level: 3322's net debt to equity ratio (16.9%) is considered satisfactory.
Reducing Debt: 3322's debt to equity ratio has reduced from 38.5% to 34.9% over the past 5 years.
Debt Coverage: 3322's debt is not well covered by operating cash flow (7.5%).
Interest Coverage: Insufficient data to determine if 3322's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 03:00 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Win Hanverky Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|